Skip to main content
All lobbying filings

AMERICANS FOR HOMEOPATHY CHOICE ACTION

Lobbying for AMERICANS FOR HOMEOPATHY CHOICE ACTION · Protecting public access to safe and genuine homeopathic medicines

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$10,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 3
  • Food & Drug Administration (FDA)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

Promoting legislation to protect public access to safe and genuine homeopathic medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem